Assessing the Swallowing Function in Children with Spinal Muscular Atrophy: An Easily Accessible and Objective Multidimensional Approach.

Spinal muscular atrophy muscular atrophy neuromuscular disease oral pressures outcome measure swallowing

Journal

Journal of neuromuscular diseases
ISSN: 2214-3602
Titre abrégé: J Neuromuscul Dis
Pays: Netherlands
ID NLM: 101649948

Informations de publication

Date de publication:
02 May 2024
Historique:
medline: 3 5 2024
pubmed: 3 5 2024
entrez: 3 5 2024
Statut: aheadofprint

Résumé

Spinal muscular atrophy (SMA), a genetic neuromuscular disease caused by lack of survival of motor neuron (SMN) protein, is characterized by muscular atrophy and respiratory and bulbar dysfunction. While swallowing disorders are common, they remain poorly studied. Our study aimed to explore 1) intraoral pressure measurements with the Iowa Oral Performance Instrument system and the reliability of a Swallowing Function Assessment Questionnaire (SFAQ) in healthy controls, and 2) evaluate their use as swallowing function biomarkers and the evolution of swallowing function over time in children with SMA. We recruited 53 healthy children and 27 SMA patients all treated with SMN gene modulator therapy. Participants completed the SFAQ and underwent at least one measurement of maximal oral pressures (lingual, labial, and masseter). Mean oral normalized pressure index were lower (all sites p < 0.001) and mean SFAQ scores were higher (p < 0.001) in patients compared with healthy controls. Pressure evolution over 1 year in SMA patients for all three oral sites did not show significant differences. SFAQ scores correlated negatively with oral pressures at all three sites in patients. Both tools provided new insights on the oral and pharyngeal phase of swallowing in SMA patients. In SMA patients, muscle strength in certain crucial anatomical regions during swallowing is weaker than in healthy children.

Sections du résumé

Background UNASSIGNED
Spinal muscular atrophy (SMA), a genetic neuromuscular disease caused by lack of survival of motor neuron (SMN) protein, is characterized by muscular atrophy and respiratory and bulbar dysfunction. While swallowing disorders are common, they remain poorly studied.
Objectives UNASSIGNED
Our study aimed to explore 1) intraoral pressure measurements with the Iowa Oral Performance Instrument system and the reliability of a Swallowing Function Assessment Questionnaire (SFAQ) in healthy controls, and 2) evaluate their use as swallowing function biomarkers and the evolution of swallowing function over time in children with SMA.
Methods UNASSIGNED
We recruited 53 healthy children and 27 SMA patients all treated with SMN gene modulator therapy. Participants completed the SFAQ and underwent at least one measurement of maximal oral pressures (lingual, labial, and masseter).
Results UNASSIGNED
Mean oral normalized pressure index were lower (all sites p < 0.001) and mean SFAQ scores were higher (p < 0.001) in patients compared with healthy controls. Pressure evolution over 1 year in SMA patients for all three oral sites did not show significant differences. SFAQ scores correlated negatively with oral pressures at all three sites in patients.
Conclusions UNASSIGNED
Both tools provided new insights on the oral and pharyngeal phase of swallowing in SMA patients. In SMA patients, muscle strength in certain crucial anatomical regions during swallowing is weaker than in healthy children.

Identifiants

pubmed: 38701158
pii: JND240017
doi: 10.3233/JND-240017
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Charlotte Colot (C)

Paediatric Neurology Department and Neuromuscular Reference center; Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles (ULB), Brussels, Belgium.

Sarah Benmechri (S)

Paediatric Neurology Department and Neuromuscular Reference center; Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles (ULB), Brussels, Belgium.

Elke Everaert (E)

Neuromuscular Reference Center (NMRC) Universitair Ziekenhuis (UZ Gent), Ghent, Belgium.

Sarah Muys (S)

Neuromuscular Reference Center (NMRC) Universitair Ziekenhuis (UZ Gent), Ghent, Belgium.

Linde Van Himme (L)

Neuromuscular Reference Center (NMRC) Universitair Ziekenhuis (UZ Gent), Ghent, Belgium.

Valentine Tahon (V)

Neuromuscular Reference Center (NMRC) Universitair Ziekenhuis (UZ Gent), Ghent, Belgium.

Maurine Salmon (M)

Department of Biomedical Research; Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.

Dorine Van Dyck (D)

Paediatric Neurology Department and Neuromuscular Reference center; Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles (ULB), Brussels, Belgium.

Elke De Vos (E)

Neuromuscular Reference Center (NMRC) Universitair Ziekenhuis (UZ Gent), Ghent, Belgium.

Nicolas Deconinck (N)

Paediatric Neurology Department and Neuromuscular Reference center; Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Neuromuscular Reference Center (NMRC) Universitair Ziekenhuis (UZ Gent), Ghent, Belgium.

Classifications MeSH